Feedback / Questions
RhuDex (AV 1142742) - Active Biotech, Dr Falk, Medigene
Corporate Presentation
(MediGene)
-
Nov 29, 2012 -
Anticipated initiation of P2 POC study for several autoimmune diseases in 2012/2013
Anticipated new P2 trial
•
Immunology
http://www.larvolonline.com/tlg/ccdb/MedigeneCorporatePresentationNov292012.PDF
Nov 29, 2012
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.